FDA Points the Way to Transition EUA SARS-CoV-2 Tests to Full Approval by Glenn S. Demby | Jan 19, 2022 | Articles, Clinical Diagnostics Insider, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register
Omicron Forces FDA to Temporarily Shut Down Inspections by Glenn S. Demby | Jan 12, 2022 | Articles, Enforcement-nir, Essential, National Lab Reporter... This content is for Paid Members only.Login Register
FDA Lists 27 Current COVID-19 Tests that May Not Detect Omicron by Glenn S. Demby | Dec 14, 2021 | Articles, COVID-19, Essential, FDA-nir, National Lab Reporter... This content is for Paid Members only.Login Register
HHS Restores Agency’s Premarket Review of LDTs by Glenn S. Demby | Dec 3, 2021 | Articles, Essential, FDA-lir, Laboratory Industry Report... This content is for Paid Members only.Login Register
Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs) by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, Coronavirus, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.Login Register